203 related articles for article (PubMed ID: 33706638)
1. The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.
Sannomiya Y; Kaseda S; Kamura M; Yamamoto H; Yamada H; Inamoto M; Kuwazuru J; Niino S; Shuto T; Suico MA; Kai H
Ren Fail; 2021 Dec; 43(1):510-519. PubMed ID: 33706638
[TBL] [Abstract][Full Text] [Related]
2. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
[TBL] [Abstract][Full Text] [Related]
3. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
[TBL] [Abstract][Full Text] [Related]
4. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.
Kim JJ; David JM; Wilbon SS; Santos JV; Patel DM; Ahmad A; Mitrofanova A; Liu X; Mallela SK; Ducasa GM; Ge M; Sloan AJ; Al-Ali H; Boulina M; Mendez AJ; Contreras GN; Prunotto M; Sohail A; Fridman R; Miner JH; Merscher S; Fornoni A
EBioMedicine; 2021 Jan; 63():103162. PubMed ID: 33340991
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.
Omachi K; Miyakita R; Fukuda R; Kai Y; Suico MA; Yokota T; Kamura M; Shuto T; Kai H
Clin Exp Nephrol; 2017 Dec; 21(6):952-960. PubMed ID: 28176019
[TBL] [Abstract][Full Text] [Related]
6. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.
Richter H; Satz AL; Bedoucha M; Buettelmann B; Petersen AC; Harmeier A; Hermosilla R; Hochstrasser R; Burger D; Gsell B; Gasser R; Huber S; Hug MN; Kocer B; Kuhn B; Ritter M; Rudolph MG; Weibel F; Molina-David J; Kim JJ; Santos JV; Stihle M; Georges GJ; Bonfil RD; Fridman R; Uhles S; Moll S; Faul C; Fornoni A; Prunotto M
ACS Chem Biol; 2019 Jan; 14(1):37-49. PubMed ID: 30452219
[TBL] [Abstract][Full Text] [Related]
7. Deletion of discoidin domain receptor 2 attenuates renal interstitial fibrosis in a murine unilateral ureteral obstruction model.
Li X; Bu X; Yan F; Wang F; Wei D; Yuan J; Zheng W; Su J; Yuan J
Ren Fail; 2019 Nov; 41(1):481-488. PubMed ID: 31169440
[No Abstract] [Full Text] [Related]
8. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
[TBL] [Abstract][Full Text] [Related]
9. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
[TBL] [Abstract][Full Text] [Related]
10. STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.
Yokota T; Omachi K; Suico MA; Kamura M; Kojima H; Fukuda R; Motomura K; Teramoto K; Kaseda S; Kuwazuru J; Takeo T; Nakagata N; Shuto T; Kai H
Nephrol Dial Transplant; 2018 Feb; 33(2):214-223. PubMed ID: 28992339
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention.
Trono P; Ottavi F; Rosano' L
Matrix Biol; 2024 Jan; 125():31-39. PubMed ID: 38081526
[TBL] [Abstract][Full Text] [Related]
12. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
[TBL] [Abstract][Full Text] [Related]
13. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1.
Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D
J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980
[TBL] [Abstract][Full Text] [Related]
14. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
Bansod S; Saifi MA; Godugu C
Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
[TBL] [Abstract][Full Text] [Related]
16. Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of Alport syndrome.
Koga T; Kai Y; Fukuda R; Morino-Koga S; Suico MA; Koyama K; Sato T; Shuto T; Kai H
PLoS One; 2012; 7(8):e43852. PubMed ID: 22937108
[TBL] [Abstract][Full Text] [Related]
17. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
18. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome.
Guo J; Song W; Boulanger J; Xu EY; Wang F; Zhang Y; He Q; Wang S; Yang L; Pryce C; Phillips L; MacKenna D; Leberer E; Ibraghimov-Beskrovnaya O; Ding J; Liu S
Hum Gene Ther; 2019 Jul; 30(7):865-881. PubMed ID: 30808234
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity of a Human Laminin
Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
